EROAD Limited
EROAD Limited (ERDLF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for EROAD Limited (ERDLF), covering cash flow, earnings, and balance sheets.
EROAD Limited (ERDLF) Income Statement & Financial Overview
View the income breakdown for EROAD Limited ERDLF across both annual and quarterly reports.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $95.90M | $93.10M | $88.90M | $84.30M |
| Cost of Revenue | $72.10M | $70.80M | $68.20M | $88.80M |
| Gross Profit | $23.80M | $22.30M | $20.70M | -$4.50M |
| Gross Profit Ratio | $0.25 | $0.24 | $0.23 | -$0.05 |
| R&D Expenses | $16.30M | $11.80M | $5.10M | $22.35M |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $16.30M | $11.80M | $5.10M | -$1.80M |
| Total Costs & Expenses | $88.40M | $82.60M | $73.30M | $87.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $300000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $3.40M |
| Depreciation & Amortization | $11.70M | $12.90M | $20.60M | $23.70M |
| EBITDA | $14.10M | $13.30M | $20.70M | $21.00M |
| EBITDA Ratio | $0.15 | $0.14 | $0.23 | $0.25 |
| Operating Income | $7.50M | $10.50M | $15.60M | -$2.70M |
| Operating Income Ratio | $0.08 | $0.11 | $0.18 | -$0.03 |
| Other Income/Expenses (Net) | -$7.60M | -$13.20M | -$20.20M | $10.90M |
| Income Before Tax | -$100000.00 | -$2.70M | -$4.60M | -$2.40M |
| Income Before Tax Ratio | -$0.001 | -$0.03 | -$0.05 | -$0.03 |
| Income Tax Expense | $1.40M | $3.60M | $3.20M | $1.20M |
| Net Income | -$1.50M | $900000.00 | -$1.40M | -$3.60M |
| Net Income Ratio | -$0.02 | $0.010 | -$0.02 | -$0.04 |
| EPS | -$0.008 | $0.008 | -$0.01 | -$0.03 |
| Diluted EPS | -$0.008 | $0.004 | -$0.01 | -$0.03 |
| Weighted Avg Shares Outstanding | $182.95M | $117.68M | $115.37M | $132.14M |
| Weighted Avg Shares Outstanding (Diluted) | $185.65M | $195.17M | $115.36M | $132.14M |
The company's financials show resilient growth, with revenue advancing from $84.30M in Q4 2023 to $95.90M in Q2 2025. Gross profit remained healthy with margins at 25% in Q2 2025 compared to -5% in Q4 2023. Operating income hit $7.50M last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $14.10M. Net income dropped to -$1.50M, while earnings per share reached -$0.008. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan